The Infectious Diseases Channel

2 Doses of HPV Vaccine in Younger Girls May Offer Similar Protection as 3 Doses in Young Women

The JAMA Report

1:59 | Infectious Diseases, Oncology, Preventative Health, The JAMA Report

The human papillomavirus (HPV) vaccine was designed to help prevent cervical cancer. For the vaccine to be effective it must be administered before sexual activity begins. A new study examined whether girls ages 9 to 13 received the same protection from taking a 2 dose regimen versus young women age 16 to 26 who received the recommended 3 dose vaccine. Catherine Dolf has more in this week’s JAMA Report.

More in Infectious Diseases

► 1:18:26

CDC Advisory Committee on Immunization Practices: Influenza 2022-2023

Allergy / Immunology

In a meeting of the Advisory Committee on Immunization Practices in March 2023, the focus was on the respiratory disease surge in Fall 2022 in the United States, with presentations...

► 5:43:30

FDA VRBPAC Meeting: RSV Treatment

Allergy / Immunology

The focus of the 179th Meeting of Vaccines and Related Biological Products Advisory Committee was on the biologics license application for respiratory syncytial virus (RSV) vaccine recombinant, Adjuvanted (AREXVY). Experts...

► 1:35:26

Public Health Focus on Arboviral Diseases

Infectious Diseases

Moderated by Karen Krueger, MD, clinical director, Travel and Immunization Clinic, Division of Infectious Diseases, Northwestern University, Feinberg School of Medicine; panelists Jorge E. Osorio, DVM, PhD, School of Veterinary...

► 44:37

Clinical Trial Design for Emerging Infectious Diseases

Infectious Diseases

At International Centre for Diarrheal Disease Research, Bangladesh, Peter Horby, FMedSci, professor of emerging infectious diseases, Global Health Director, Pandemic Sciences Institute, Oxford University, UK, and Executive Director, International Severe Acute...